United States · FDA National Drug Code directory
RotaTeq
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-4047_4881d3df-658c-42b2-9f13-9c86ca8d4a1e
- Product NDC
- 0006-4047
- Form
- SOLUTION
- Composition / generic term
- Rotavirus Vaccine, Live, Oral, Pentavalent
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20060203
- Source listing expiry
- 20271231
Source-listed ingredients
- HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN — 2200000 [iU]/2mL
- HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN — 2800000 [iU]/2mL
- HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN — 2200000 [iU]/2mL
- HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN — 2000000 [iU]/2mL
- HUMAN ROTAVIRUS A TYPE G6P1A(8) STRAIN WI79 LIVE ANTIGEN — 2300000 [iU]/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 POUCH in 1 CARTON (0006-4047-20) / 1 TUBE in 1 POUCH (0006-4047-02) / 2 mL in 1 TUBE (0006-4047-01) · 0006-4047-20
- 10 POUCH in 1 CARTON (0006-4047-41) / 1 TUBE in 1 POUCH (0006-4047-02) / 2 mL in 1 TUBE (0006-4047-01) · 0006-4047-41
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →